Evidence-Based Medicine Guidelines
Rufinamide add‐on therapy for refractory epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rufinamide Add‐on Therapy for Refractory Epilepsy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305288/all/Rufinamide_add‐on_therapy_for_refractory_epilepsy.
Rufinamide add‐on therapy for refractory epilepsy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305288/all/Rufinamide_add‐on_therapy_for_refractory_epilepsy. Accessed October 5, 2024.
Rufinamide add‐on therapy for refractory epilepsy. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305288/all/Rufinamide_add‐on_therapy_for_refractory_epilepsy
Rufinamide Add‐on Therapy for Refractory Epilepsy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305288/all/Rufinamide_add‐on_therapy_for_refractory_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rufinamide add‐on therapy for refractory epilepsy
ID - 1305288
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305288/all/Rufinamide_add‐on_therapy_for_refractory_epilepsy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
